Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,730.00 JPY | -2.85% | -4.55% | +6.25% |
04/09 | Nexon Targets 750 Billion Yen in Sales by 2027 | MT |
19/08 | Jefferies Adjusts Nexon's Price Target to 4,870 Yen From 4,340 Yen, Keeps at Buy | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 249B | 293B | 274B | 354B | 423B | |||||
Total Revenues | 249B | 293B | 274B | 354B | 423B | |||||
Cost of Goods Sold, Total | 59.59B | 69.01B | 72.12B | 106B | 138B | |||||
Gross Profit | 189B | 224B | 202B | 248B | 285B | |||||
Selling General & Admin Expenses, Total | 66.25B | 81.91B | 82.05B | 110B | 119B | |||||
Provision for Bad Debts | - | - | - | - | 5.59B | |||||
R&D Expenses | 14.9B | 16.54B | 21B | 25.93B | 24.62B | |||||
Depreciation & Amortization - (IS) | 3.97B | 5.25B | 5.44B | 3.75B | 4.31B | |||||
Other Operating Expenses | -1.26B | -1.19B | -436M | -426M | -106M | |||||
Other Operating Expenses, Total | 83.85B | 103B | 108B | 139B | 153B | |||||
Operating Income | 105B | 121B | 94.29B | 109B | 132B | |||||
Interest Expense, Total | -401M | -357M | -415M | -588M | -1.41B | |||||
Interest And Investment Income | 13.38B | 8.28B | 6.45B | 12.99B | 24.62B | |||||
Net Interest Expenses | 12.98B | 7.92B | 6.04B | 12.4B | 23.21B | |||||
Income (Loss) On Equity Invest. | -325M | 765M | -999M | -10.25B | -3.51B | |||||
Currency Exchange Gains (Loss) | 16.23B | -17.74B | 36.43B | 41.71B | 10.44B | |||||
Other Non Operating Income (Expenses) | -180M | -189M | -388M | 656M | 95M | |||||
EBT, Excl. Unusual Items | 134B | 112B | 135B | 154B | 162B | |||||
Gain (Loss) On Sale Of Investments | 6.11B | 1.25B | 3.94B | -2.33B | 2.12B | |||||
Gain (Loss) On Sale Of Assets | -43M | -56M | -5M | -32M | -8M | |||||
Asset Writedown | -17.9B | -5.27B | -3.83B | -10.69B | -38.61B | |||||
EBT, Incl. Unusual Items | 122B | 108B | 135B | 141B | 126B | |||||
Income Tax Expense | 8.73B | 52.68B | 22.41B | 40.54B | 54.84B | |||||
Earnings From Continuing Operations | 113B | 55.49B | 113B | 99.99B | 71.08B | |||||
Net Income to Company | 113B | 55.49B | 113B | 99.99B | 71.08B | |||||
Minority Interest | 2.43B | 731M | 1.82B | 349M | -475M | |||||
Net Income - (IS) | 116B | 56.22B | 115B | 100B | 70.61B | |||||
Net Income to Common Incl Extra Items | 116B | 56.22B | 115B | 100B | 70.61B | |||||
Net Income to Common Excl. Extra Items | 116B | 56.22B | 115B | 100B | 70.61B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 129.34 | 63.57 | 128.91 | 114.74 | 82.89 | |||||
Basic EPS - Continuing Operations | 129.34 | 63.57 | 128.91 | 114.74 | 82.89 | |||||
Basic Weighted Average Shares Outstanding | 894M | 884M | 891M | 875M | 852M | |||||
Net EPS - Diluted | 128.03 | 61.9 | 126.55 | 113.81 | 82.33 | |||||
Diluted EPS - Continuing Operations | 128.03 | 61.9 | 126.55 | 113.81 | 82.33 | |||||
Diluted Weighted Average Shares Outstanding | 901M | 894M | 903M | 882M | 857M | |||||
Normalized Basic EPS | 96.23 | 80.16 | 96.98 | 110.16 | 118.62 | |||||
Normalized Diluted EPS | 95.5 | 79.3 | 95.74 | 109.27 | 117.84 | |||||
Dividend Per Share | 2.5 | 5 | 7.5 | 10 | 10 | |||||
Payout Ratio | - | 7.86 | 3.87 | 8.76 | 12.15 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 113B | 130B | 103B | 116B | 141B | |||||
EBITA | 105B | 121B | 94.29B | 109B | 132B | |||||
EBIT | 105B | 121B | 94.29B | 109B | 132B | |||||
Effective Tax Rate - (Ratio) | 7.16 | 48.7 | 16.54 | 28.85 | 43.55 | |||||
Normalized Net Income | 86.06B | 70.88B | 86.43B | 96.34B | 101B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 18.72B | 20.42B | 17.39B | 25.72B | 32.98B | |||||
Selling and Marketing Expenses | 24.04B | 27.04B | 23.14B | 32.79B | 43.52B | |||||
General and Administrative Expenses | 1.54B | 1.85B | 2.84B | 4.48B | 3.42B | |||||
Research And Development Expense From Footnotes | 14.9B | 16.54B | 21B | 25.93B | 24.62B |